Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Galectin Therapeutics Inc., 3 years.
Galectin Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 | Galectin Therapeutics Inc. | Open-market purchase | +300 | $2.70 | $810 |
| Dec 23, 2025 | Galectin Therapeutics Inc. | Open-market purchase | +700 | $3.73 | $2,611 |
| Dec 23, 2025 | Galectin Therapeutics Inc. | Open-market purchase | +700 | $3.73 | $2,611 |
| Jul 21, 2025 | Galectin Therapeutics Inc. | Open-market purchase | +1,000 | $2.93 | $2,930 |
| Dec 24, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +13,469 | $0.82 | $11,045 |
| Oct 23, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +500 | $2.60 | $1,300 |
| Jan 16, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +500 | $1.79 | $895 |
| Jan 16, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +400 | $2.39 | $956 |
| Jul 19, 2023 | Galectin Therapeutics Inc. | Open-market purchase | +1,598 | $1.79 | $2,860 |
| Feb 21, 2023 | Galectin Therapeutics Inc. | Open-market purchase | +1,000 | $1.59 | $1,590 |
| Jan 25, 2023 | Galectin Therapeutics Inc. | Open-market purchase | +1,300 | $1.11 | $1,443 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.